Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4221193 | Clinical Imaging | 2016 | 8 Pages |
Abstract
Lung cancer remains the leading cause of cancer-related death in the United States. An effective screening tool for early lung cancer detection has long been sought. Early chest radiograph and low-dose computed tomography (LDCT) screening trials were promising and demonstrated increased cancer detection. However, these studies were not able to improve lung cancer mortality. The National Lung Screening Trial resulted in decreased lung cancer mortality with LDCT screening in a high-risk population. Similar trials are currently underway in Europe. With LDCT now being widely implemented, it is paramount for radiologists to understand the evidence for lung cancer screening.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Kathleen Ruchalski, Antonio Gutierrez, Scott Genshaft, Fereidoun Abtin, Robert Suh,